General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries

Abstract

Background General practitioners (GPs) should regularly review patients’ medications and, if necessary, deprescribe, as inappropriate polypharmacy may harm patients’ health. However, deprescribing can be challenging for physicians. This study investigates GPs’ deprescribing decisions in 31 countries. Methods In this case vignette study, GPs were invited to participate in an online survey containing three clinical cases of oldest-old multimorbid patients with potentially inappropriate polypharmacy. Patients differed in terms of dependency in activities of daily living (ADL) and were presented with and without history of cardiovascular disease (CVD). For each case, we asked GPs if they would deprescribe in their usual practice. We calculated proportions of GPs who reported they would deprescribe and performed a multilevel logistic regression to examine the association between history of CVD and level of dependency on GPs’ deprescribing decisions. Results Of 3,175 invited GPs, 54% responded (N = 1,706). The mean age was 50 years and 60% of respondents were female. Despite differences across GP characteristics, such as age (with older GPs being more likely to take deprescribing decisions), and across countries, overall more than 80% of GPs reported they would deprescribe the dosage of at least one medication in oldest-old patients (> 80 years) with polypharmacy irrespective of history of CVD. The odds of deprescribing was higher in patients with a higher level of dependency in ADL (OR =1.5, 95%CI 1.25 to 1.80) and absence of CVD (OR =3.04, 95%CI 2.58 to 3.57). Interpretation The majority of GPs in this study were willing to deprescribe one or more medications in oldest-old multimorbid patients with polypharmacy. Willingness was higher in patients with increased dependency in ADL and lower in patients with CVD.

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study

“…However, prescription rates of lipid modifying agents decreased markedly beyond 80 years of age in both sexes. This finding might be the result of many GPs’ willingness to de-prescribe these medications for patients in primary prevention of cardiovascular diseases ( Jungo et al, 2021 ). Similarly, the prescription rates of antiinflammatory and antirheumatic products decreased in the older.…”

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study

“… 60 A case vignette study conducted in 31 European countries among older patients to investigate GPs deprescribing decision reported that most of the GPs were willing to deprescribe, especially for patients with multimorbidity. 61 Higher likelihood of polypharmacy among women with higher GP visits in our study could be indicative of a need for effective implementation of interprofessional collaboration of GPs, pharmacists, and nurses to promote deprescribing and enable non-pharmacological supports. 62 …”

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial

“…The sex composition of the OPTICA GPs could affect the final results, since female physicians have been found to be less likely to make deprescribing decisions [46]. We found that the multimorbid older patients who participated in the OPTICA trial were comparable to those in the FIRE database in terms of sociodemographic variables, health services use and clinical characteristics.…”